In metabolomics, the detection of new biomarkers from NMR spectra is a promising approach. However, this analysis remains difficult due to the lack of a whole workflow that handles spectra pre-processing, automatic identification and quantification of metabolites and statistical analyses. We present ASICS, an R package that contains a complete workflow to analyse spectra from NMR experiments. It contains an automatic approach to identify and quantify metabolites in a complex mixture spectrum and uses the results of the quantification in untargeted and targeted statistical analyses. ASICS was shown to improve the precision of quantification in comparison to existing methods on two independant datasets. In addition, ASICS successfully recovered most metabolites that were found important to explain a two level condition describing the samples by a manual and expert analysis based on bucketting. It also found new relevant metabolites involved in metabolic pathways related to risk factors associated with the conditions. This workflow is available through the R package ASICS, available on the Bioconductor platform.
This article focuses on NMR data, that is a promising tool to detect interesting 12 biomarkers. The most common approach to deal with 1 H NMR spectra is to first divide 13 them into intervals called buckets. The areas under the curve are computed for every 14 bucket and every spectrum and these data are given as inputs to statistical methods to 15 provide a list of buckets of interest (for instance buckets that are significantly different 16 between two conditions). Since buckets are not directly connected to metabolites, this 17 approach requires that 1 H NMR experts identify the metabolites from the extracted 18 buckets. Not only is this identification step tedious, time consuming, expert dependent 19 and not reproducible but it also leads to a serious loss of information since the identi-20 fication of metabolites is restricted to the ones that correspond to extracted buckets 21 (Considine et al., 2018) . (Cañueto et al., 2018) ); see Bingol (2018) for a complete review. Recently, 27 Tardivel et al. (2017) defined a new statistical method to automatically identify and 28 quantify metabolites that outperforms the other approaches. However, the approach 29 mainly focuses on the quantification step and needed to be embedded in a complete pre- 30 processing and post-processing analysis workflow, available through a simple tool. To our 31 knowledge, such analysis workflows already existed (see a review in Misra (2018)) but they 32 were usually restricted to some steps of the global analysis (post-processing, bucketing or 33 statistical analysis). The only exception seems to be the W4M e-infrastructure (Guitton 34 et al. (2017) , available through the Galaxy platform 1 ), whose automatic identification 35 and quantification step is based on an earlier version of ASICS but the environment 36 only allows one-by-one spectrum analysis. Furthermore, none of the existing workflow is 37 as flexible, easily installed and embedded with other tools than an R package can be.
38
The R package ASICS (Automatic Statistical Identification in Complex Spectra) was 39 thus designed to fill this gap. The identification and quantification method is partially 40 based on but has been strongly tested, revisited and improved to 41 provide a fine tuning of all the parameters of the original approach.
Data importation and preprocessing
Metabolite quantification or bucketing
Statistical analyses
Importation of multiple spectra from Bruker or other type files
Data importation
Creation of a library of pure spectra (one spectrum by metabolite) Factor of interest with at least two levels (find differences between two or more conditions) Figure 1 . Schematic representation of ASICS workflow. Bottom box (with brown background): supplementary data (factor corresponding to experimental conditions for the different spectra) are required for this part of the analysis.
Baseline correction Most of
1 H NMR spectra have baseline distortions coming from 53 various sources like instrument instability. These distortions can induce an increase or a 54 decrease in peak intensities and skew the results of quantification. Wang et al. (2013) 55 developed a method to estimate the baseline for a spectrum by classifying each point 56 as a signal or a noise point and by using a linear interpolation between noise points to 57 construct the baseline. Then, the baseline is subtracted from its spectrum.
58
Peak alignment Due to pH or temperature variations between the acquisition of 59 multiple spectra, peak positions of the same metabolite can change between spectra. 60 It is better to align all peaks before analyses, especially if a binning algorithm is used. 61 Vu et al. (2011) developed an algorithm, implemented in the R package speaq, to carry 62 out this alignment. It is based on continuous wavelet transform to detect peaks and 63 hierarchical clustering to align all spectra on a reference one.
64
Removal of unwanted regions It is also frequent to exclude a part of the spectra 65 from the analysis. For instance, the part corresponding to water (4.5-5.1 ppm) is of 66 no interest for most biological analyses and thus frequently removed prior to statistical 67 analyses. Urea region (5.5-6.5 ppm) is also frequently excluded in case of urine samples. 68 Normalisation A normalisation is mandatory before any analysis to make samples 69 comparable. It allows to minimise systematic variations due to differences in sample 70 dilutions. One of the most used methods is the normalisation to a constant sum (Craig 71 et al. (2006)). As a result, the total spectral intensity is the same for each spectrum.
72
In ASICS, all preprocessing steps are available and the normalisation is the only 73 mandatory one (it is systematically performed when the data are loaded). In the two 74 following steps of the quantification method (preprocessing of the reference library, 75 described in Section 2.2, and quantification itself, described in Section 2.3), all complex 76 mixture spectra are processed individually and independently from each other. The 77 method is thus described for only one complex mixture spectrum (and repeated similarly 78 for all the others). 
Preprocessing the reference library

80
A library of pure metabolite spectra is used as a reference to identify and quantify 81 metabolite concentrations in the (complex mixture) spectra of interest. This library is a 82 set of spectra of pure compounds, that have been acquired independently from samples. 83 Such a reference library is available in ASICS. This library is composed of 190 spectra 84 for which the noise has already been removed (Supplementary Data 1). The spectra 85 acquisition procedure is detailed in . In addition, ASICS provides 86 functions to add or remove some spectra from the available reference library or to use 87 another (user provided) reference library.
88
In addition to removing noise of each library spectrum, preprocessing steps are needed 89 to clean and adapt the library to each spectrum of interest.
90
Noise thresholding As this is the case for each 1 H NMR spectrum, all spectra in 91 library contain noise. All values below a certain threshold, s l , (that can be defined by 92 the user; default value is s l = 1), are considered as noise and set to 0. This allows to 93 select peak positions, a step that is critical for the next selection stage.
94
First selection step A metabolite can not belong to the complex mixture if at least 95 one peak of its spectrum does not appear in the complex mixture spectrum peaks. Using 96 this simple property, a first selection step is performed. All spectra in the reference 97 4/14 library for which the peaks are not included in the peaks of the complex mixture spectrum 98 are removed. This step results in a reference library of p pre-selected reference spectra 99 that are used in the model described in Section 2.3. As technical biases can yield to 100 chemical shifts, a reference spectrum is selected if all its peaks are present in the complex 101 mixture spectrum with an allowed shift of M ppm between the two spectra. In addition, 102 as complex mixture spectra are noisy, peaks under a threshold s m are ignored for this 103 identification step. By default, the maximum allowed shift is M = 0.02 ppm and the 104 threshold is s m = 0.02. However, both values can be changed by the user, depending on 105 his spectrometer and experimental conditions.
106
Translation and distortion The alignment algorithm described in Section 2.1 can 107 not be used to align reference spectra with the complex mixture spectrum. The reason 108 is that this method is not adapted to spectra with a low number of peaks as those of the 109 pure metabolite contained in the reference library. A two step procedure is used instead 110 (Figure 2 
Metabolite quantification
126
Using the preprocessed complex mixture spectrum and the preprocessed spectra of the reference library, the metabolite identification and quantification in the complex mixture spectrum is performed as described in . The complex mixture spectrum is defined as a linear combination of the library reference spectra:
with
where g corresponds to the complex mixture spectrum, f i • Φ i to the p pre-selected pre-127 processed spectra of the reference library, β = (β 1 , . . . , β p ) to the coefficients associated 128 with these spectra (or, equivalently, with the corresponding metabolites) and to the 129 noise. The noise is structured so as to take into account both an additive noise, 2 , and 130 a multiplicative noise, 1 : =
131
A variable selection procedure is implemented to obtain a sparse β by controlling 132 the Family Wise Error Rate (FWER) with a risk α. Usually, the threshold for rejecting 133 H 0 : β i = 0 is the same for every i. Here, we used the procedure described in Tardivel the acceptance region, namely arg min (bi)i
..,p are MLE estimates of Equation (1). The solution of 138 this optimization problem is obtained by simulating a large number of realizations of 139 the random variable Z ∼ N (0, Σ), where Σ is the estimated variance of the estimates 140 (β i ) i so as to have
, and the 141 thresholds (b i ) are obtained as the 1 − α quantile of the random variable {|Z 1 |, . . . , |Z p |}, 142 that allows to control the FWER.
143
Once the metabolites selected, the quantifications (β i ) i for those selected metabolites 144 are re-estimated by restricting Equation (1) to this subset in order to limit estimation 145 bias. Finally, the relative quantifications are obtained by dividing (β i ) i by the respective 146 number of protons of each selected metabolite.
147
In ASICS, pure library preprocessing and quantification are implemented in a unique 148 function that can be run at once for several spectra with a parallel computing backend. 149
Post-quantification statistical analyses
150
On quantified metabolites (or on a subset of metabolites that are sufficiently frequently 151 observed in the whole set of complex mixture spectra), the following analyses can be 152 performed, using the spectra alone or a two level factor of interest that describes the 153 samples:
154
Quantification assessment To assess the quality of ASICS quantification, a plot 155 with the original complex mixture spectrum, g(t), and the reconstructed spectrum, 156 p i=1 β i f i (Φ i (t)), can be obtained for a given sample (Supplementary Figure S1) . In 157 addition, one reference spectrum for a given metabolite, and its distorted spectrum, can 158 be superimposed to this plot in order to assess the quality of the metabolite selection for 159 metabolites of interest. (Thévenot et al., 2015) . To avoid overfitting, a 10-fold 168 cross-validation procedure is implemented. Prediction error and variable importance 169 in projection (VIP) are computed on ten OPLS-DA and averaged over the ten folds. 170 Moreover, a stability index is created to find influential metabolites (i.e., metabolites 171 with a VIP superior to a predefined threshold) common to most folds. As for PCA, 172 individual and variable plots are available (Supplementary Figure S3) . Figure S4) . . In order to 185 explore the development of the metabolic status in late gestation, an experiment was 186 performed on pig fetuses. Metabolomic data were acquired on plasma samples collected 187 on n = 155 Large White (LW) fetuses at 90 days of gestation and on n = 128 fetuses at 188 110 days of gestation (birth is around 114 days; ANR PORCINET project). All 1 H NMR 189 spectra were phased and baseline corrected. Glucose, fructose, and lactate were directly 190 quantified by standard methods (they have been chosen as indicators of carbohydrate 191 metabolism). More details about the experimental design and data acquisition can be 192 found in Supplementary Section S2.
173
Statistical tests
To answer the same type of questions, statistical tests have also 174 been implemented. Since relative quantifications are usually non normally distributed, 175 Kruskal-Wallis tests are used to find differences between the two (or more) groups, 176 in combination with a correction for multiple testing, as available in the R function 177 p.adjust. Boxplots showing the differences in metabolite quantification between the 178 conditions can be displayed (Supplementary
193
Similar analyses were performed on buckets and on relative quantifications computed 194 with ASICS to assess the performance of the method. The aim of these analyses was to 195 find differentially concentrated metabolites between two groups: fetuses at 90 and 110 196 days of gestation. Lists of metabolites obtained with both approaches were compared 197 as well as the direction of change between groups, based on two OPLS-DA, one on 198 buckets and the other on quantifications obtained with ASICS. VIP thresholds for both 199 OPLS-DA were set to 1.
200
Metabolites that were quantified were used to make a quantitative assessment of 201 ASICS by comparing the obtained (estimated) quantifications with the dosages. Pearson 202 correlation between quantifications and dosages were computed for every metabolite 203 directly measured by dosage. These correlations were also compared with the correla-204 tions obtained for other quantification methods: Autofit, batman, Bayesil and rDolphin. 205 Contrary to ASICS, these methods were too slow or not automated to allow the quantifi-206 cation for the 283 spectra. Therefore, quantifications were performed on a subsample of 207 7/14 the original dataset that corresponded to the deciles of the lactate, fructose and glucose 208 dosage to ensure representativity (32 spectra). Computational times were also recorded. 209 For ASICS quantifications, water and urea regions were excluded and the maximum 210 shift, M , was set to 0.01. In order to perform all quantifications with batman in a 211 reasonable time, its library was reduced to the 160 common metabolites between batman 212 and ASICS reference libraries and the number of iterations was set to 10,000. 
Urinary metabolome of Type 2 diabetes mellitus
214
In order to test our method on data acquired with another spectrometer than the one 215 on which the pure metabolite library included in ASICS has been obtained, we used the 216 public datasets from Salek et al. (2007) . The experiment has been designed to improve 217 the understanding of early stage of type 2 diabetes mellitus (T2DM) development. 218 1 H NMR human metabolome was obtained from 84 healthy volunteers and 50 T2DM 219 patients. Raw 1D Bruker spectral data files were found in the MetaboLights database 220 (Haug et al. (2013) ; study MTBLS1). In the original study, spectra were normalized by 221 the area under the curve after excluding water (4.24-5.04 ppm), urea (5.04-6.00 ppm) 222 and glucose (3.19-3.99 ppm, 5.21-5.27 ppm) regions. Finally, a bucketing was performed 223 with a 0.04-ppm width. The original study used a combination of PLS-DA and statistical 224 tests (t-test, F -test, Kruskal-Wallis test and Kolmogorov-Smirnov test) on buckets (with 225 a manual expert identification) to find differences between the healthy and ill individuals. 226 This dataset allowed us to test the performance of ASICS on a different fluid (urine) in 227 a different species (human).
228
Contrary to Salek et al. (2007) , we kept glucose region for a quantification with 229 ASICS because the glucose spectrum was available in the library. However, regions of 230 water and urea were excluded. The other parameters of the different methods were set 231 to their default values except for ASICS threshold that was set to s m = 0.05, because we 232 had observed that this dataset was noisier than the previous one. In addition, to control 233 differences that could originate from the differential analysis method itself, we performed 234 the comparison between the buckets and the ASICS quantifications approaches with 235 OPLS-DA, as for the study about perinatal survival (VIP thresholds set to 1.2). Correlations between quantifications and biochemical dosages of the three metabolites 239 were performed on the 32 selected spectra. We were not able to obtain quantifications 240 with Bayesil because no chemical shift reference (TSP) has been added during spectrum 241 acquisition. Bayesil handles spectrum from raw NMR induction-decay signal and so it 242 requires that spectra are collected with TSP added to the sample (Beirnaert et On a practical point of view, ASICS has other interesting features: first, it provides 259 an easy way to handle (complement, replace, manipulate) the reference library whereas 260 batman and rDolphin need that information on each multiplet (chemical shift position, 261 multiplicity. . . ) is specified. A biochemical expertise is thus required for the modification 262 of the reference library in these packages. Autofit is a commercial software that requires 263 the acquisition of a license, which strongly limits its use. Finally, the reference library 264 cannot be modified in Bayesil and this method is only available through a web interface 265 that makes automation of several spectra processing impossible.
266
In terms of computational times, the preprocessing of the library and the metabolite 267 quantification with ASICS takes about 1'30 min per spectrum and can be launched at 268 once in parallel. A parallel environment is also available for batman but the quantification 269 of a single spectra takes approximately 2 days. Computational time needed by rDolphin 270 is approximately the same than for ASICS but parallel implementation is not proposed 271 in the package. Only Autofit has a lower computation time than ASICS (less than one 272 minute) but spectra can only be quantified sequentially (no parallel environment).
273
A table summarizing capabilities of each method is available in Supplementary 274 Table S3 . 
Differences between gestational ages of fetuses
276
For the study about fetuses in late gestation, two outliers were detected on the bucket 277 dataset in a preliminary study (Supplementary Figure S5) and were removed from the 278 analysis ( Supplementary Figures S6 and S7 ).
279
OPLS-DA was performed on quantified metabolites and on buckets. Both showed the 280 same predicting power: all samples were perfectly separated according to their stages of 281 gestation. For the bucket analysis, VIP values identified 268 buckets on 781 that were 282 found influential to separate the two groups. Based on this list, a manual identification 283 performed by an NMR expert hightlighted 21 metabolites.
284
The same analysis was performed on the ASICS quantifications and allowed to 285 obtain 22 metabolites. The results obtained by ASICS and buckets analysis are detailed 286 in Supplementary Table S4 . Nine metabolites were found common to both analyses 287 (Supplementary Figure S8) : lactate, creatinine, fructose, glucose, threonine, valine, 288 9/14 alanine, proline and leucine. For the metabolites which were not identified by both 289 approaches, we observed five cases:
290
• metabolites only identified on buckets because the pure spectra was not present in 291 the ASICS reference library: the 3-methyl-2-oxovaleric acid and the lipids;
292
• metabolites that were not found by ASICS because differences between the two 293 groups are significative with Kruskal-Wallis tests but not found large enough to be 294 selected by the OPLS-DA: the betaine and the glutamic acid;
295
• metabolites with low intensity peaks because ASICS was not able to identify and 296 quantify smaller quantities: citrate, tyrosine, lysine, creatine and isoleucine;
297
• metabolites that were found by ASICS and not by the bucket analysis but for 298 which all peaks corresponded to buckets that were found influential in the bucket 299 analysis: the glycine and the guanidinoacetic acid. For this case, it is very likely 300 that the non identification of these metabolites comes from an expertise bias (peaks 301 are confused with glucose and fructose thus the expert does not identify it);
302
• metabolites for which no clear conclusion could be driven on their presence without 303 expert knowledge in NMR or biology or the help of other technologies like 2D NMR 304 spectrometry. For ASICS analysis these metabolites correspond to metabolites 305 whose spectra have peaks only in the region with a high density of peaks (3.5 306 to 4.2 ppm; threonic acid, xylitol, sorbitol, galactitol, glucolic acid and arabitol), 307 with a low concentration (N-acetylglycine, acetamidomethylcysteine, arginine and 308 isovaleric acid) or with peaks confused with glucose peaks (glucose-6-phosphate). 309
The metabolites found by ASICS are consistent with known biological processes 310 of late gestation in pig, especially with the fetal two-fold increase of weight during 311 the last three weeks. It is expected to find up-regulation of the protein synthesis in 312 late gestation, which is illustrated by the increase of amino acid abundances (alanine, 313 proline, threonine, arginine, leucine, valine) just before birth. Also, functional analysis 314 performed with IPA (see Supplementary Figure S9 ) highlighted 13 metabolites (among 315 the 22 identified by ASICS) involved in common metabolic pathways directly related to 316 late stage gestation (survival or organism, metabolism of protein, conversion of lipid). 317 Among these metabolites, 6 (guanidinoacetic acid, sorbitol, glucose-6-phosphate, glycine, 318 gluconic acid and arginine) were identified only by ASICS and not with the bucket 319 approach. In this study, the only weakness of ASICS is thus a tendency to miss low 320 concentrated metabolites, especially if those have peaks only in the region with a high 321 density of peaks. 
Differences for T2DM patients
323
Results for the T2DM study are provided in Supplementary Table S4 and in Supple-324 mentary Figure S10 . The same conclusions than in Section 4.2 can be driven: some 325 metabolites were extracted by both analyses (creatinine, betaine, hippuric acid, guani-326 dinoacetic acid, alanine, glucose, indoxylsulfate, acetoacetate and trigonelline), some 327 did not have a pure spectra available in the library (phenylacetylglycine and 2PY) and 328 the ASICS algorithm had difficulties to identify metabolites with low concentrations 329 (3-hydroxybutyrate, isoleucine, 2-oxoisovalerate, fumaric acid and butyrate) or with only 330 one proton (allantoin). Table S4 ). Those comparisons highlighted the relevance of ASICS quantification that 336 showed results consistent with previous studies and prior knowledge on Type 2 diabete: 337 some of the metabolites were extracted by ASICS and by bucket quantification, like 338 alanine or acetoacetate (Supplementary Table S4) , and have also been identified in 339 Salek et al. (2007) . We were also able to extract other metabolites, like the glucose 340 (D-Glucose), the guanidinoacetic acid or the glycerol, that were not previously described 341 because the glucose region was excluded from the study in Salek et al. (2007) . The 342 glycerol was identified both by ASICS and by Salek et al. (2007) in experiments on rats 343 and mice (the glucose region was only excluded in the human dataset and not in the rat 344 and mouse datasets). In all experiments, the glycerol increased in diabetics, which might 345 reflect changes in fatty acids metabolism. With ASICS, the creatinine and its precursor, 346 the guanidinoacetic acid (both also found with buckets), were directly quantified in urine 347 and only the creatinine was previously described in (Salek et Yousri et al. (2015) in urine of patients. Together with glucose-6-phosphate, also only 358 identified with ASICS, these metabolites reflect the pentose pathway activity in diabetics. 359 Metabolites associated to this pathway were also previously identified in urine as strongly 360 associated with T2DM development in a diabetic rat model (Sun et al., 2014) . Finally, 361 only ASICS allowed the identification of GABA (γ-aminobutyric acid), a neuromediator 362 recently identified to be increased in T2DM and related to a lower cognitive functioning 363 observed in some diabetic patients (Van Bussel et al., 2016).
364
In conclusion, not only was ASICS able to automatically recover the main findings of 365 the bucket and expert analysis, it was also able to extract a number of metabolites that 366 are relevant and confirmed by other independent studies but not found by the bucket and 367 expert analysis (glycerol, guanidinoacetic acid, acetone, arabitol, glucose-6-phosphate 368 and GABA). This untargeted approach allowed to highlight several metabolic pathways 369 linked to Type 2 Diabete Mellitus, as illustrated in Supplementary Figure S11.
370
Conclusion
371
This article presents an R package, ASICS, integrating a complete analysis workflow of 372 1 H NMR spectra. This pipeline integrates an automatic metabolite identification and 373 quantification method based on a reference library of pure metabolite spectra. ASICS 374 showed better quantification results than existing methods and allowed to perform a 375 complete study on several hundreds spectra in only a few hours. Its use on two real 376 world datasets exhibited similar results than the standard analysis on buckets followed 377 by expert manual identification but also allowed to provide new information. For both 378 studies, new metabolites, not extracted by expert identification, were found by ASICS, 379 some of them confirmed by previous and independent studies. Obviously, as is the case 380 for other omics data, in coming to a conclusion on whether the metabolites were really 381 present in samples, a validation would be necessary. This validation could be performed 382 with other technologies, like 2D NMR spectrometry, or specific biochemical dosages but 383 is out of the scope of the present article.
384
Finally, ASICS still has some limitations: the algorithm had difficulties to identify 385 11/14 metabolites with low concentrations or with their peaks all located in a region with 386 a high density of peaks. Future work will tackle this aspect, by trying to couple the 387 information from the whole set of spectra to improve the individual quantification. 
